Long-time interval info from an early first-line trial of pembrolizumab (Keytruda) plus chemotherapy confirmed that extra than half of patients with progressed non-squamous non-limited cell…
Immunotherapy for gastric and esophageal cancer bought make stronger from three novel reviews reported all the plan during the 2020 European Society for Scientific Oncology…
In stepped forward melanoma, PD-1 blockade with pembrolizumab (Keytruda) used to be effective no matter sufferers’ BRAF mutation living, retrospective recordsdata from three KEYNOTE trials…